ABBOTT BIOTHERAPEUTICS CORP
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Unregistered equity sale · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsApr 23, 2010
- Regulation FD disclosureApr 5, 2010
- Entered a material agreement · Modified shareholder rights · Other material eventMar 10, 2010
- Results of operationsFeb 26, 2010
- Regulation FD disclosureFeb 9, 2010
- Terminated a material agreementFeb 3, 2010
- Entered a material agreementJan 26, 2010
- Regulation FD disclosureJan 11, 2010
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- CT ORDERNov 8, 2010
- SC 13G/ASep 27, 2010
- 4Sep 27, 2010
- 15-12BMay 3, 2010
- CT ORDERApr 28, 2010
- 8-KApr 23, 2010
- 4PRIMARY DOCUMENTApr 23, 2010
- 4PRIMARY DOCUMENTApr 23, 2010
- 4PRIMARY DOCUMENTApr 23, 2010
- 4PRIMARY DOCUMENTApr 23, 2010
- 4PRIMARY DOCUMENTApr 23, 2010
- 4PRIMARY DOCUMENTApr 23, 2010
- 4PRIMARY DOCUMENTApr 23, 2010
- 4PRIMARY DOCUMENTApr 23, 2010
- 4PRIMARY DOCUMENTApr 23, 2010
Corporate family
Spun off from PDL BioPharma · Dec 18, 2008
From the spin-off filings we track. Follow a company to walk its own history.
Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.